Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
Author(s):
Heijde, D. van der; Deodhar, A.; Fleischmann, R.; Mease, P.J.; Rudwaleit, M.; Nurminen, T.; Davies, O.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-07-31
Language
English
Is part of
Arthritis Care and Research (2017), Vol. 69, no. 7, p. 1030-1039
